Defence Therapeutics CEO outlines three strategic priorities in letter

Go back to Defence Therapeutics CEO outlines three strategic priorities in letter
(NYSE: DTC) Delayed: 19.55 --0 (-0%)
Previous Close $19.55    52 Week High
Open $19.55    52 Week Low
Day High $19.55    P/E N/A 
Day Low $19.55    EPS
Volume 601,153       

(AMEX: DTCFF) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High
Open $0.36    52 Week Low
Day High $0.36    P/E N/A 
Day Low $0.36    EPS
Volume 1,703